Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.
Relating to the exclusion from the market value of real property for ad valorem tax purposes of the value of any incomplete structure located on the property.